Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

13.77
Delayed Data
As of Sep 19
 -0.02 / -0.15%
Today’s Change
8.31
Today|||52-Week Range
27.84
-5.17%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Operating ActivitiesNet Income / Starting Line-1.2B-462.3M629.0M-41.7M
 
 
 
 
 
Depreciation698.9M649.1M674.0M656.4M
 
 
 
 
 
Total Other Cash Flow1.3B262.4M-25.0M-144.7M
 
 
 
 
 
Funds From Operations591.0M530.4M324.0M226.6M
 
 
 
 
 
Funds From/For Other Operating Expenses58.9M58.1M-592.0M-31.1M
 
 
 
 
 
Net Cash Flow - Operating Activities532.1M472.4M916.0M257.7M
 
 
 
 
 
 
InvestingIncrease In Investments21.2K431.2K0.00-992.1K
 
 
 
 
Decrease In Investments1.1M95.8K0.00992.1K
 
 
 
 
Capital Expenditures-51.8M-50.8M-38.0M-36.4M
 
 
 
 
 
Fixed Asset Disposal18.7M63.9M1.3B810.1M
 
 
 
 
 
Net Assets From Acquisitions 736.1K30.7M-9.0M9.0M
 
 
 
 
 
Other Investing - Uses0.00-29.8M0.000.00
 
 
Net Cash Flow Investing-69.6M9.5M1.1B773.8M
 
 
 
 
 
 
FinancingShort Term Borrowings-411.4K3.1M-1.0M-5.9M
 
 
 
 
 
Long Term Borrowings-18.5M-20.9M6.2B-51.1M
 
 
 
 
 
Long Term Debt Reduction-635.8M-488.9M-7.6B-158.3M
 
 
 
 
 
Net Proceeds Stock Sale32.9M-669.6K0.000.00
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing----------
Other Uses - Financing44.9M39.7M9.0M28.7M
 
 
 
 
 
Net Cash Flow - Financing-666.8M-538.7M-1.4B-244.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash3.1M-60.1M8.0M15.8M
 
 
 
 
 
 
Net Change In Cash-204.2M-56.7M660.0M787.5M